What is Angeliq?
Angeliq is a prescription medication used for the treatment of moderate to severe vasomotor symptoms (hot flashes and night sweats) due to menopause [1]. It is also indicated for the prevention of postmenopausal osteoporosis [1].
What are the active ingredients in Angeliq?
Angeliq contains two active ingredients: drospirenone and estradiol [1]. Drospirenone is a progestin, and estradiol is a form of estrogen [1].
When will Angeliq become available as a generic?
Information regarding specific generic availability for Angeliq is not publicly detailed here. However, drug patent and exclusivity timelines, which dictate when generics can enter the market, can be tracked through resources like DrugPatentWatch.com [2].
What is the difference between Angeliq and other hormone therapy options?
Angeliq combines drospirenone and estradiol, offering a specific formulation for menopausal symptom management and osteoporosis prevention [1]. Other hormone therapy options may contain different combinations of estrogens and progestins, or be available in different dosage forms or strengths. The choice of therapy often depends on individual patient needs and medical history.
What are the potential risks or side effects of Angeliq?
Like other hormone therapies, Angeliq carries potential risks and side effects. These can include an increased risk of blood clots, stroke, heart attack, and certain types of cancer (such as breast cancer and endometrial cancer) [1]. Common side effects may include breast tenderness, headache, nausea, and mood changes [1]. Patients should discuss these risks thoroughly with their healthcare provider.
Can Angeliq be used for birth control?
Angeliq is not indicated for use as a contraceptive [1]. Its primary uses are for menopausal symptom relief and osteoporosis prevention.